Transarterial chemoembolization in the treatment of primary and recurrent pelvic tumors with peritoneal involvement: what results can be expected?

Transarterial chemoembolization (TACE) with drug-saturated microspheres is used in the treatment of women with pelvic tumors complicated by bleeding. Another serious problem is peritoneal carcinomatosis. However, it has not been studied whether TACE affects peritoneal lesions, is there a difference...

Full description

Saved in:
Bibliographic Details
Main Authors: E. A. Zvezdkina, A. G. Kedrova, D. P. Lebedev, T. A. Greyan, D. N. Panchenkov, Yu. A. Stepanova
Format: Article
Language:Russian
Published: ABV-press 2022-09-01
Series:Опухоли женской репродуктивной системы
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/974
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849773656114200576
author E. A. Zvezdkina
A. G. Kedrova
D. P. Lebedev
T. A. Greyan
D. N. Panchenkov
Yu. A. Stepanova
author_facet E. A. Zvezdkina
A. G. Kedrova
D. P. Lebedev
T. A. Greyan
D. N. Panchenkov
Yu. A. Stepanova
author_sort E. A. Zvezdkina
collection DOAJ
description Transarterial chemoembolization (TACE) with drug-saturated microspheres is used in the treatment of women with pelvic tumors complicated by bleeding. Another serious problem is peritoneal carcinomatosis. However, it has not been studied whether TACE affects peritoneal lesions, is there a difference in peritoneal lesions with primary and recurrent tumors? The purpose of this article is to analyze the results of TACE in women with peritoneal lesions with primary and recurrent pelvis tumors. This is an analysis of 80 patients with primary tumors (group 1) and 20 patients with recurrent tumors of pelvis (group 2). 8 women in group 1 and 11 women in group 2 had an implantation lesion of peritoneum near the main focus, 3 women in group 1 and 4 women in group 2 had a peritoneum lesion at a distance from the main focus. Angiography revealed differences in blood supply of implantation metastases in the group of primary and recurrent tumors, as well as the blood supply of distant peritoneal metastases. These facts should be taken into account in order to reduce the number of errors in assessing the effectiveness of therapy, to obtain a good clinical result, and to avoid discrediting TACE due to unreasonable requirements for it.
format Article
id doaj-art-d7a5a19bfbbb499f83fc5be5e8fce617
institution DOAJ
issn 1994-4098
1999-8627
language Russian
publishDate 2022-09-01
publisher ABV-press
record_format Article
series Опухоли женской репродуктивной системы
spelling doaj-art-d7a5a19bfbbb499f83fc5be5e8fce6172025-08-20T03:01:59ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272022-09-01182869210.17650/1994-4098-2022-18-2-86-92740Transarterial chemoembolization in the treatment of primary and recurrent pelvic tumors with peritoneal involvement: what results can be expected?E. A. Zvezdkina0A. G. Kedrova1D. P. Lebedev2T. A. Greyan3D. N. Panchenkov4Yu. A. Stepanova5O.K. Skobelkin State Research Center for Laser Medicine, Federal Medical and Biological Agency of the Russian FederationFederal Research and Clinical Center for Specialized Medical Care and Medical Technologies, Federal Medical and Biological Agency of the Russian FederationFederal Research and Clinical Center for Specialized Medical Care and Medical Technologies, Federal Medical and Biological Agency of the Russian FederationFederal Research and Clinical Center for Specialized Medical Care and Medical Technologies, Federal Medical and Biological Agency of the Russian FederationA.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of RussiaA.V. Vishnevsky National Medical Research Center for Surgery, Ministry of Health of RussiaTransarterial chemoembolization (TACE) with drug-saturated microspheres is used in the treatment of women with pelvic tumors complicated by bleeding. Another serious problem is peritoneal carcinomatosis. However, it has not been studied whether TACE affects peritoneal lesions, is there a difference in peritoneal lesions with primary and recurrent tumors? The purpose of this article is to analyze the results of TACE in women with peritoneal lesions with primary and recurrent pelvis tumors. This is an analysis of 80 patients with primary tumors (group 1) and 20 patients with recurrent tumors of pelvis (group 2). 8 women in group 1 and 11 women in group 2 had an implantation lesion of peritoneum near the main focus, 3 women in group 1 and 4 women in group 2 had a peritoneum lesion at a distance from the main focus. Angiography revealed differences in blood supply of implantation metastases in the group of primary and recurrent tumors, as well as the blood supply of distant peritoneal metastases. These facts should be taken into account in order to reduce the number of errors in assessing the effectiveness of therapy, to obtain a good clinical result, and to avoid discrediting TACE due to unreasonable requirements for it.https://ojrs.abvpress.ru/ojrs/article/view/974chemoembolizationrecurrent tumorcervical canceruterine cancermagnetic resonance imaginghepasphereperitoneal carcinomatosisangiographytumor afferents
spellingShingle E. A. Zvezdkina
A. G. Kedrova
D. P. Lebedev
T. A. Greyan
D. N. Panchenkov
Yu. A. Stepanova
Transarterial chemoembolization in the treatment of primary and recurrent pelvic tumors with peritoneal involvement: what results can be expected?
Опухоли женской репродуктивной системы
chemoembolization
recurrent tumor
cervical cancer
uterine cancer
magnetic resonance imaging
hepasphere
peritoneal carcinomatosis
angiography
tumor afferents
title Transarterial chemoembolization in the treatment of primary and recurrent pelvic tumors with peritoneal involvement: what results can be expected?
title_full Transarterial chemoembolization in the treatment of primary and recurrent pelvic tumors with peritoneal involvement: what results can be expected?
title_fullStr Transarterial chemoembolization in the treatment of primary and recurrent pelvic tumors with peritoneal involvement: what results can be expected?
title_full_unstemmed Transarterial chemoembolization in the treatment of primary and recurrent pelvic tumors with peritoneal involvement: what results can be expected?
title_short Transarterial chemoembolization in the treatment of primary and recurrent pelvic tumors with peritoneal involvement: what results can be expected?
title_sort transarterial chemoembolization in the treatment of primary and recurrent pelvic tumors with peritoneal involvement what results can be expected
topic chemoembolization
recurrent tumor
cervical cancer
uterine cancer
magnetic resonance imaging
hepasphere
peritoneal carcinomatosis
angiography
tumor afferents
url https://ojrs.abvpress.ru/ojrs/article/view/974
work_keys_str_mv AT eazvezdkina transarterialchemoembolizationinthetreatmentofprimaryandrecurrentpelvictumorswithperitonealinvolvementwhatresultscanbeexpected
AT agkedrova transarterialchemoembolizationinthetreatmentofprimaryandrecurrentpelvictumorswithperitonealinvolvementwhatresultscanbeexpected
AT dplebedev transarterialchemoembolizationinthetreatmentofprimaryandrecurrentpelvictumorswithperitonealinvolvementwhatresultscanbeexpected
AT tagreyan transarterialchemoembolizationinthetreatmentofprimaryandrecurrentpelvictumorswithperitonealinvolvementwhatresultscanbeexpected
AT dnpanchenkov transarterialchemoembolizationinthetreatmentofprimaryandrecurrentpelvictumorswithperitonealinvolvementwhatresultscanbeexpected
AT yuastepanova transarterialchemoembolizationinthetreatmentofprimaryandrecurrentpelvictumorswithperitonealinvolvementwhatresultscanbeexpected